Amprologix selected to pitch at the World Innovation…
10 October 2022October 2022 CSO Mat Upton joined 19 other start-ups that were selected from 700 applicants for a place at the…
October 2022 CSO Mat Upton joined 19 other start-ups that were selected from 700 applicants for a place at the…
April 2022 Gordon Barker, Amprologix CEO was selected to present our innovative antibiotic development approach at the Start-ups Session (https://amr-conference.com/start-ups-amr-conference-pitching-session/).…
January 2022 Amprologix and RefLab ApS (Copenhagen, Denmark) have collaborated on a project using an ex vivo human skin microdialysis model (below)…
November 2021 Amprologix have contracted two leading Commercial Research Organisations to conduct pre-clinical work on lead compound, epidermicin NI01. Amprologix…
We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record…
We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record in early stage financing and bring a wealth of life science sector experience to the team.
Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to the Derriford Research Facility to accommodate our expansion plans as we transition into the clinical phase of our antibiotic discovery programmes.
